Hannah SyedClinician
diabetes specialist pharmacist at East Sussex Healthcare NHS Trust and co-chair of the UK Clinical Pharmacy Association's diabetes and endocrinology committee
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“Once-weekly insulin efsitora is an important development that could reduce treatment burden for many people with T2DM, particularly those who require support with insulin administration. Appropriate patient selection, education and clear implementation guidance will be key to its successful adoption.”
diabetes specialist pharmacist at East Sussex Healthcare NHS Trust and co-chair of the UK Clinical Pharmacy Association's diabetes and endocrinology committee · Diabetes · 27 Aug 2026 · Once-weekly insulin would be ‘significant change’ for diabetes prescribers ↗
Source references
- Once-weekly insulin would be ‘significant change’ for diabetes prescriberspharmaceutical-journal.com · 27 Aug 2026
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.